Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1988 | 12-1987 | 12-1986 | 12-1985 | 12-1984 | |
Cash Flows From Operating Activities | |||||
Net Income | -8,294 | -3,100 | 3,008 | -3,311 | N/A |
Depreciation Amortization | 81 | 62 | -44 | 40 | N/A |
Other Working Capital | 1,060 | N/A | N/A | N/A | N/A |
Other Operating Activity | 1,473 | -1,913 | -211 | 451 | 0 |
Operating Cash Flow | $-5,680 | $-4,951 | $2,753 | $-2,821 | $N/A |
Cash Flows From Investing Activities | |||||
PPE Investments | -30 | N/A | N/A | N/A | N/A |
Other Investing Activity | 351 | 364 | 5,354 | 4,536 | 0 |
Investing Cash Flow | $322 | $364 | $5,354 | $4,536 | $N/A |
Cash Flows From Financing Activities | |||||
Other Financing Activity | 5,033 | 16 | 8,105 | 1,781 | 0 |
Financing Cash Flow | $5,033 | $16 | $8,105 | $1,781 | $N/A |
Beginning Cash Position | 1,537 | 264 | 8,107 | 69 | N/A |
End Cash Position | 1,211 | -4,851 | N/A | 1,647 | N/A |
Net Cash Flow | $-326 | $218 | $16,212 | $4 | $N/A |
Free Cash Flow | |||||
Operating Cash Flow | -5,680 | -4,951 | 2,753 | -2,821 | N/A |
Free Cash Flow | -5,680 | -4,951 | 2,753 | -2,821 | 0 |